PI Industries
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
PI Industries is undergoing a strategic transformation aimed at diversifying its revenue streams and enhancing long-term growth potential. Management's focus on scaling its Pharma CRDMO and Biologicals segments, supported by a robust R&D infrastructure, is critical as the company navigates a challenging global agrochemical environment characterized by weak demand and pricing pressures. Despite near-term margin pressures due to rising raw material costs and geopolitical uncertainties, the company's strong balance sheet and disciplined capital allocation provide a solid foundation for future growth. Vista's financial outlook reflects an expectation of accelerating revenue growth beyond historical levels, although margins are likely to remain under pressure. The anticipated recovery in global agrochemical demand and the successful commercialization of proprietary products like Pioxaniliprole are pivotal for achieving Vista's target prices of INR 2461 and INR 2686 over the next 12 and 24 months, respectively. Key opportunities include the scaling of high-value innovation and the expansion of the biologicals portfolio, while watchpoints include the volatility of raw material costs and the potential impact of geopolitical tensions on supply chains
Why We Like This Stock
- Management's focus on high-value innovation and diversification into Pharma CRDMO and Biologicals is expected to drive long-term growth
- The company's strong balance sheet, with significant net cash, provides flexibility for ongoing R&D and strategic investments
- A robust order book of $1.2 billion supports revenue stability and positions the company for recovery in global agrochemical demand
Things To Watch Out For
- Near-term earnings are pressured by rising raw material costs and geopolitical uncertainties impacting margins
- The core CSM business faces cyclical slowdowns and inventory destocking, which may hinder short-term performance
- Potential volatility in global supply chains and climatic unpredictability pose risks to operational stability
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 7,666 | 7,978 | 6,714 | 6,679 | 7,022 |
| Profit Before Tax (Cr.) | 1,897 | 2,145 | 1,593 | 1,408 | 1,559 |
| PBT Margin | 24.7% | 26.9% | 23.7% | 21.1% | 22.2% |
| Net Profit (Cr.) | 1,540 | 1,713 | 1,270 | 1,123 | 1,243 |
| Earnings Per Share | 101.3 | 112.7 | 83.6 | 73.9 | 81.8 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Axis Securities | ▲ Buy | 3,045 | 13-Aug-2026 |
| Citigroup | ▼ Sell | 2,375 | 13-Aug-2026 |
| Deven Choksey | ► Accumulate | 2,833 | 13-Aug-2026 |
| HSBC | ► Hold | 2,720 | 13-Aug-2026 |
| Jeffries | ▲ Outperform | 2,910 | 13-Aug-2026 |
| Motilal Oswal | ▲ Buy | 3,000 | 13-Aug-2026 |
| Prabhudas Liladhar | ► Hold | 2,569 | 13-Aug-2026 |
| DAM Capital | ▼ Sell | 2,556 | 21-May-2026 |
| Morgan Stanley | ▲ Overweight | 3,883 | 21-May-2026 |
Company Overview
Show Company Profile
PI Industries Limited, together with its subsidiaries, manufactures and distributes of agricultural chemicals in India, rest of Asia, North America, Europe, and internationally. It operates through Agro Chemicals and Pharma segments. The company offers agrochemicals, including insecticides, fungicides, herbicides, and biologicals; crop solutions for soybeans, chili, sugarcane, rice, wheat, cotton, and corn, as well as horticulture products; and plant nutrients and specialty chemicals. It also provides custom synthesis and manufacturing services to other companies; and pharmaceuticals, medicinal chemical, and botanical products. The company sells its products to farmers, distributors, retailers, and sellers. It also exports its products. PI Industries Limited was incorporated in 1946 and is based in Gurugram, India.